Joint-Flex
Joint-Flex, licence 80076970: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Joint Complex, Joint Formula
- Licence holder
- Natural Immix Health Ltd.
- NPN or DIN-HM
- 80076970
- Status
- Inactive licence
- Licence date
- 26 April 2017
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 6 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 33.333 milligramme | 99,999 µg |
| Niacinamide Source : Saccharomyces cerevisiae - en entier | 8.333 milligramme | Not calculated |
| Bêta-Alanine, N-((2R)-2,4-dihydroxy-3,3-diméthyl-1-oxobutyl)-, Sel de calcium (2:1) Source : D-Pantothénate de calcium | 8.333 milligramme | Not calculated |
| Manganèse Source : Produit de chélation de manganèse et d'acide aminé | 2.0 milligramme | 6,000 µg |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de sodium provenant d¿exosquelettes de crabes | 500.0 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Chondroïtine sulfate de sodium extrait de Bos taurus - Cartilage | 266.666 milligramme | Not calculated |
| Boswellia serrata Source : Gum oleoresin Extract : Matériel brut sec Extraction ratio : 0.4:1 Dry plant equivalent : 13.333 milligramme Potency : 13.33 milligramme Boswellic acids | 33.333 milligramme | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 33.333 milligramme | Not calculated |
| Curcuma longa Source : Racine Extract : Matériel brut sec Extraction ratio : 0.948:1 Dry plant equivalent : 15.8 milligramme Potency : 15.8 milligramme Curcumin | 16.666 milligramme | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 8.333 milligramme | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 27000000.0 Papain Units | Not calculated |
| Vitis Vinifera Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10.001:1 Dry plant equivalent : 33.333 milligramme | 3.333 milligramme | Not calculated |
| 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Quercétine dihydraté | 3.333 milligramme | Not calculated |
| Zingiber officinale Source : Racine | 16.666 milligramme | Not calculated |
| L-Proline Source : L-Proline | 16.666 milligramme | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 40.0 milligramme | Not calculated |
| Collagène de type II hydrolysé Source : Gallus gallus - cartilage | 6.666 milligramme | Not calculated |
Non-medicinal ingredients
phosphate de dicalcium, Cellulose microcristalline, Stéarate de magnésium, Acide stéarique, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain associated with osteoarthritis (of the knee). Helps to protect against the deterioration of cartilage. A factor in maintaining good cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80076970
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.